Neumirna Therapeutics ApS

Neumirna is a biotechnology company founded in 2020 that specializes in developing miRNA-based therapies to address the root causes of neurological disorders. \n The company focuses on restoring neural network balance by targeting microRNAs, which are critical regulators of gene expression. \n Their...